GE Enhances Tender Offer for Arcam AB
GE (NYSE: GE) today announced that it has changed the terms of its tender offer for all of the outstanding shares of Arcam AB of Sweden, and has extended the acceptance period through 5 p.m. CET on November 10.
GE has increased the offer price for each Arcam share to 300 SEK. GE will not further increase the price of the offer. GE has also reduced the minimum acceptance threshold to 75%.
The Arcam board of directors continues to unanimously recommend that Arcam's shareholders accept GE's offer.
“We have taken further steps to pursue Arcam ownership as we advance our additive strategy,” said David Joyce, GE vice chairman and president and CEO of GE Aviation. “We are delighted to achieve the strategic cornerstone in our additive strategy by announcing today our acquisition of Concept Laser. The Arcam offer is a next step in our strategy. We have become the partner of choice in the additive space and are receiving numerous requests for alternative ways to accelerate our strategy.”
As a leading end user of additive today, GE is committed to driving the additive revolution by providing world-class equipment and technologies to customers across several industries.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
BEARINGPOINT22.2.2018 09:32 | pressemeddelelse
BearingPoint: How Firms Transform into Digital Superpowers
NC-ELI-GLOBAL-LLC22.2.2018 09:02 | pressemeddelelse
Eli Global to Acquire Lead Generation Marketplace Finanzen
FERRING-PHARMACEUTICALS22.2.2018 07:02 | pressemeddelelse
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage
THE-NIPPON-FOUNDATION22.2.2018 06:04 | pressemeddelelse
The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational
MA-VERTEX-PHARMA21.2.2018 22:03 | pressemeddelelse
Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis
AZ-UNIVERSAL-LASER21.2.2018 19:02 | pressemeddelelse
Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum